INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 115 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | – | 50 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 50 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 50 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 50 | -99.1% | 0.00% | – |
| Q2 2016 | $70,000 | -18.6% | 5,400 | 0.0% | 0.00% | – |
| Q1 2016 | $86,000 | -93.7% | 5,400 | -88.7% | 0.00% | -100.0% |
| Q4 2015 | $1,367,000 | +1.3% | 47,705 | +0.6% | 0.01% | 0.0% |
| Q3 2015 | $1,349,000 | -36.9% | 47,405 | -20.4% | 0.01% | -27.3% |
| Q2 2015 | $2,138,000 | +23.7% | 59,520 | +100.0% | 0.01% | +22.2% |
| Q1 2015 | $1,729,000 | +70.2% | 29,760 | +23.5% | 0.01% | +80.0% |
| Q4 2014 | $1,016,000 | – | 24,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |